Dendreon (DNDN) is one again in the news. At first, it appears that there is a faster track that the FDA is allowing when it comes to the trials for Provenge. If you read the news item it is really nothing significant, yet it is may be a hint...
DHUnplugged #379: Slow GrindOct 18, 2017
DHUnplugged #378: The Best Stock Market in The WorldOct 11, 2017
DHUnnplugged #377: We Have FrameworkOct 04, 2017
DHUnplugged #376: Jumpy, Sloppy, TweetySep 27, 2017
DHUnplugged #375: A Breach Of ConfidenceSep 20, 2017